ECVAM's ongoing activities in the area of acute oral toxicity

Toxicology in Vitro

Volumn 23, Issue 8, 2009, Pages 1535-1540

  Kinsner Ovaskainen, Agnieszka ^a   Bulgheroni, Anna ^a   Hartung, Thomas ^b   Prieto, Pilar ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

3Rs; Acute toxicity; Cytotoxicity; Validation

Indexed keywords

NEUTRAL RED; TOXIC SUBSTANCE;

ACUTE TOXICITY; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ARTICLE; CELL STRAIN 3T3; CYTOTOXICITY TEST; EXPERIMENTAL ANIMAL WELFARE; EXPERIMENTAL DESIGN; FOLLOW UP; IN VIVO STUDY; LD 50; NONHUMAN; PREDICTION; TOXICITY TESTING; VALIDATION STUDY;

ACUTE TOXICITY TESTS; ADMINISTRATION, ORAL; ANIMAL TESTING ALTERNATIVES; ANIMALS; BALB 3T3 CELLS; HUMANS; LETHAL DOSE 50; MICE; NEUTRAL RED; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RATS;

ANIMALIA;

EID: 70350702677     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.07.004     Document Type: Article

References (28)

1. Anon, 2001. Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity. NIH Publication No. 01-4499. (accessed June 2009).
2. Anon, 2003. Directive 2003/15/EC of the European Parliament and the Council of 27 February amending Directive 76/786/EEC on the approximation of the laws of the member States relating to cosmetic products. Official Journal of the European Communities L66, 26-35. Office for Official Publications of the European Communities, Luxembourg.
3. Anon, 2005. REACH and the need for intelligent testing strategies. Ispra, Italy, Institute for Health and Consumer Protection, E.C. Joint Research Centre [EUR 21554 EN], 1-32.
4. Anon, 2006. Background Review Document (BRD): Validation of Neutral Red Uptake Test Methods. NIH Publication No. 07-4518. (accessed June 2009).
5. Anon, 2007. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L396, 1-856. Office for Official Publications of the European Communities, Luxembourg.
6. Anon, 2008. Validation Study of In Vitro Cytotoxicity Test Methods: Recommendations and Agency Responses. (accessed June 2009).
7. Blaauboer B.J. The necessity of biokinetic information in the interpretation of in vitro toxicity data. Alternatives to Laboratory Animals (ATLA) 30 2 (2003) 85-91
8. Bulgheroni A., Kinsner-Ovaskainen A., Hoffmann S., Hartung T., and Prieto P. Estimation of acute oral toxicity using the No Adverse Effect Level (NOAEL) from the 28-day repeated dose toxicity studies in rats. Regulatory Toxicology and Regulatory Toxicology and Pharmacology 53 (2009) 16-19
9. Combes R., Grindon C., Cronin M.T., Roberts D.W., and Garrod J.F. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation. Alternatives to Laboratory Animals (ATLA) 36 (2008) 45-63
10. Clemedson C., and Ekwall B. Overview of the final MEIC results: I. The in vitro - in vitro evaluation. Toxicology in Vitro 13 (1999) 657-663
11. Clemedson C., Blaauboer B., Castell J., Prieto P., Risteli L., Vericat J.A., and Wendel A. ACuteTox - optimisation and pre-validation of an in vitro test strategy for predicting human acute toxicity. ALTEX 23 (2006) 254-258
12. Clemedson C. The European ACuteTox project: a modern integrative in vitro approach to better prediction of acute toxicity. Clinical Pharmacology and Therapeutics 84 (2008) 200-202
13. Clothier R., Dierickx P., Lakhanisky T., Fabre M., Betanzos M., Curren R., Sjöström M., Raabe H., Bourne N., Hernandez V., Mainez J., Owen M., Watts S., and Anthonissen R. A database of IC50 values and principal component analysis of results from six basal cytotoxicity assays, for use in the modelling of the in vivo and in vitro data of the EU ACuteTox project. Alternatives to Laboratory Animals (ATLA) 36 (2008) 503-519
14. Ekwall B., Clemedson C., Crafoord B., Ekwall Ba., Hallander S., Walum E., and Bondesson I. MEIC evaluation of acute systemic toxicity: Part V: Rodent and human toxicity data for the 50 reference chemicals. Alternatives to Laboratory Animals (ATLA) 26 (1998) 569-615
15. European Commission, 2007. Proposal for a regulation of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, and amending Directive 67/548/EEC and Regulation (EC) No 1907/2006. COM(2007) 355 final.
16. Eskes C., and Zuang V. Alternative (Non-Animal) methods for cosmetics testing: Current status and future prospects. A report prepared in the context of the 7th Amendment of the Cosmetics Directive for establishing the timetable for phasing out animal testing. Alternatives to Laboratory Animals (ATLA) 33 1 (2005) 1-228
17. Forsby A., and Blaauboer B. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Human and Experimental Toxicology 26 (2007) 333-338
18. Gennari A., van den Berghe C., Casati S., Castell J., Clemedson C., Coecke S., Colombo A., Curren R., Dal Negro G., Goldberg A., Gosmore C., Hartung T., Langezaal I., Lessigiarska I., Maas W., Mangelsdorf I., Parchment R., Prieto P., Sintes J.R., Ryan M., Schmuck G., Stitzel K., Stokes W., Vericat J.A., and Gribaldo L. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50. Alternatives to Laboratory Animals (ATLA) 32 (2004) 437-459
19. Gundert-Remy U., and Sonich-Mullin C. IPCS Uncertainty and Variability Planning Workgroup and Drafting Group (International Program on Chemical Safety's). The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective. The Science of the Total Environment 288 (2002) 3-11
20. Halle W. The registry of cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals. Alternatives to Laboratory Animals (ATLA) 31 (2003) 89-198
21. Hartung T., Bremer S., Casati S., Coecke S., Corvi R., Fortaner S., Gribaldo L., Halder M., Hoffmann S., Roi A.J., Prieto P., Sabbioni E., Scott L., Worth A., and Zuang V. A modular approach to the ECVAM principles on test validity. Alternatives to Laboratory Animals (ATLA) 32 (2004) 467-472
22. Kinsner-Ovaskainen A., Rzepka R., Rudowski R., Coecke S., Cole T., and Prieto P. Acutoxbase, an innovative database for in vitro acute toxicity studies. Toxicology In Vitro 23 (2009) 476-485
23. Organisation for Economic Cooperation and Development, 2001a. Guideline for Testing of Chemicals Number 420 on Acute Oral Toxicity - Fixed Dose Procedure. Paris, France.
24. Organisation for Economic Cooperation and Development, 2001b. Guideline for Testing of Chemicals Number 423 on Acute Oral Toxicity - Acute Toxic Class Method. Paris, France.
25. Organisation for Economic Cooperation and Development 2001 (c). Guideline for Testing of Chemicals Number 425 on Acute Oral Toxicity - Up- And Down Procedure. Paris, France.
26. Organisation for Economic Cooperation and Development, 2001d. Series on Testing and Assessment Number 24: Guidance Document on Oral Toxicity Testing, ENV/JM/MONO(2001)4. Paris, France.
27. Sjöström M., Kolman A., Clemedson C., and Clothier R. Estimation of human blood LC50 values for use in modeling of in vitro-in vivo data of the ACuteTox project. Toxicology In Vitro 22 (2008) 1405-1411
28. United Nations, 2007. Globally Harmonized System of Classification and Labelling of Chemicals (GHS), ST/SG/AC.10/30/Rev.2. (accessed October 2008).